Cardium Files 510(k) for ExcellagenXL Topical Gel and Flowable Collagen

Cardium Therapeutics announced Thursday that its wholly-owned subsidiary, Tissue Repair Company, submitted a 510(k) premarket notification filing with the U.S. FDA seeking marketing clearance of its Excellagen product candidate based on positive data from the Company’s recently completed Phase 2b Matrix clinical study.
StreetInsider